NTRA250117C210000
- 0.40
- -2.26-84.96%
Natera Newsroom
Craig-Hallum Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $174
Craig-Hallum Sticks to Their Buy Rating for Natera (NTRA)
Natera Is Maintained at Buy by Canaccord Genuity
Natera Analyst Ratings
CCORF Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $180
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)
TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $195
Natera Is Maintained at Overweight by JP Morgan
Natera Analyst Ratings
J.P. Morgan Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $200
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $200
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
UBS Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $209
UBS Adjusts Price Target on Natera to $209 From $145, Maintains Buy Rating
Natera Is Maintained at Overweight by Piper Sandler
Natera Analyst Ratings
Natera Analyst Ratings
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $176
A Quick Look at Today's Ratings for Natera(NTRA.US), With a Forecast Between $150 to $185
Morgan Stanley Adjusts Natera Price Target to $176 From $132, Maintains Overweight Rating